This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Voyager Therapeutics, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Patrick Starremans
Introduction
Patrick Starremans is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of biotechnology, particularly in the development of analytical tools for viral vectors. His work is crucial for advancing gene therapy techniques.
Latest Patents
Patrick holds a patent titled "Methods for measuring the potency of AADC viral vectors." This patent presents improved analytical tools, systems, and methods related to AADC viral vectors. It includes AADC potency assays for measuring and analyzing AADC expression potency, specifically focusing on enzymatic activity related to AADC vectors such as adeno-associated virus (AAV) AADC vectors. He has 1 patent to his name.
Career Highlights
Patrick is currently employed at Voyager Therapeutics, Inc., where he continues to innovate in the field of gene therapy. His expertise in viral vector technology has positioned him as a key player in the biotechnology sector.
Collaborations
Throughout his career, Patrick has collaborated with notable colleagues, including Joseph Mombeleur and Eric D Horowitz. These partnerships have enhanced his research and contributed to the advancement of their shared goals in biotechnology.
Conclusion
Patrick Starremans exemplifies the spirit of innovation in biotechnology through his patent and work at Voyager Therapeutics, Inc. His contributions are paving the way for future advancements in gene therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile